Of note, LAMC2 has been previously identified as a specific marker for tumor budding in multiple tumor types, including CRC18, and we confirmed that its expression correlated with EMP1 mRNA in CRC patient samples (Extended Data Fig. 7e,g). Here, EMP1 is linked to neoplasm.